INGN News & Events

For the full year 2026, Inogen expects reported revenue in the range of $366 million to $373 million, reflecting approximately 6% growth at the midpoint of the range relative to the Company's 2025 revenue. The Company remains committed to driving positive Adjusted EBITDA improvement in 2026.

Inogen expects first quarter 2026 reported revenue to be in line with first quarter 2025, due to channel mix and lower expected U.S. rentals revenue driven by reimbursement mix and reduced patients on service.

Reports Q4 revenue $81.7M, up 2% year-over-year. "In 2025, we made significant progress toward our long-term profitability goals while strengthening our product portfolio and improving the fundamentals of our business. Our disciplined operational efficiency contributed to a substantial year-over-year improvement in adjusted EBITDA, culminating in a positive result for the first time since 2021," said Kevin Smith, President and Chief Executive Officer. "Our strong balance sheet with no debt, puts us in a strong position to accelerate innovation, enhance customer engagement, and drive portfolio expansion in 2026 and beyond. We believe these strategic achievements create a solid foundation for future growth and value creation for our shareholders."

Inogen announced that its Board of Directors has authorized a share repurchase program for up to $30M of its outstanding common stock. "This authorization reflects our confidence in Inogen's strategy, progress towards profitability goals, and long-term growth trajectory," said Kevin Smith, President and Chief Executive Officer. "With a strong, debt-free balance sheet, we view this program as providing additional flexibility to deploy capital to support continued investment in innovation and portfolio expansion while enhancing shareholder value."